News from the healthcare data industry
CHICAGO and KANSAS CITY, Mo., Dec. 21, 2021 /PRNewswire/ — EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition of Intouch Group®, a full-service global...
NEW YORK and OTTAWA, ON, Jan. 4, 2022 /PRNewswire/ — Aetion, the leading regulatory-grade real-world evidence (RWE) technology provider, today announced that it has acquired Replica Analytics, a pioneer in using artificial intelligence (AI)...
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced a...
By Tamra Sami PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) has undertaken a massive effort to reform its drug and device regulations, and as it pulls into the homestretch with those reforms,...
31 Dec 2021 NEWS Vibha Sharma Executive Summary The UK Medicines and Healthcare products Regulatory Agency has finalized the first part of a series of new guidance documents addressing issues...
During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option to the patient in question is limited by the quantity and quality of...
ROCHESTER, Mich., Dec. 29, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”)(Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced its Evidence-based Physician Engagement...
Bill Evans, chief marketing officer at Komodo Health, joins Steve Madden live from the floor of the HLTH conference to discuss how the company’s Healthcare Map is serving as a...
Author: Dr. Matthew Roe and Rebecca HancockDecember 2021BackTwitterFacebookLinkedIn Verana Health recently shared comments with the Food and Drug Administration sharing our support for its draft guidance document, “Real-World Data: Assessing...
The companies will reportedly focus on exploring real-world evidence and conducting clinical trials through G42 Healthcare’s Contract Research Organisation, IROS.By Rachel McArthurDecember 24, 202108:37 AM Credit: iStock AstraZeneca has teamed...